Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Beyond Scalp: New study Suggests Role for Elissara® in Hair Growth


News provided by

Monteloeder, S.L.

Sep 01, 2026, 07:00 ET

Share this article

Share toX

Share this article

Share toX

Preclinical findings demonstrate nutricosmetic by Monteloeder may offer broad support to hair resilience

Key Takeaways

  • New preclinical research reveals Elissara® activity across multiple pathways associated with healthy hair growth
  • Elissara® shown to help preserve growth-signalling IGF-1 protein levels important for hair-follicle development under environmental stress
  • The findings extend Elissara®'s clinically demonstrated scalp benefits to include follicular resilience
  • Monteloeder will present the study results at Vitafoods Asia and SupplySide Global.

MADRID, Sept. 1, 2026 /PRNewswire/ -- Results of a new study show that Elissara®, a nutricosmetic by Monteloeder, SL, a subsidiary of SuanNutra, SA, exhibits multifactorial activity associated with healthy hair growth and hair follicle function. The four-botanical polyphenol-enriched ingredient demonstrated support of hair follicle function and hair resilience.

Hair appearance, and particularly hair loss, is a major concern affecting millions of men and women worldwide and has a substantial impact on self-esteem and social confidence.

Continue Reading
Beyond Scalp: New study Suggests Role for Elissara® in Hair Growth
Beyond Scalp: New study Suggests Role for Elissara® in Hair Growth

"Consumers are increasingly concerned about their hair's appearance and are seeking natural, science-backed solutions that support hair vitality," explains Mariana Ortega, Science Marketing Manager for SuanNutra. "Supplement brands are responding to the growing demand for hair health solutions. The category is evolving from multivitamins targeting hair, skin, and nails toward more advanced, targeted products. We empower supplement brands with a complete beauty-from-within toolkit, enabling them to develop next-generation solutions that complement consumers' healthy lifestyles and go beyond topical care."

"Elissara is a great example of Visible Radiance™, our branded beauty-from-within line. "This science-driven platform designed as 'plug-in' line for beauty brands," adds Ortega.

Elissara® is a proprietary combination of four herbs formulated to work together to support the scalp's environment for more vibrant and healthier looking hair. It includes standardized extracts of lemon verbena (Lippia citriodora), olive leaf (Olea europaea), Japanese pagoda tree (Styphnolobium japonicum), and rosemary (Rosmarinus officinalis).

The preparation delivers a specific fingerprint of bioactive compounds, including: verbascoside, oleuropein, hydroxytyrosol, quercetin, and rosemary-derived diterpenes (carnosol and carnosic acid). Together, these phenolic compounds provide a broad spectrum of antioxidant and anti-inflammatory activity

Getting to the root of hair growth

This three-pronged preclinical trial, published in the August 2026 issue of the journal Biomolecules involved laboratory assessments of human dermal papilla cells and scalp tissue samples exposed to environmental stressors such as pollution and UV light. Results showed that Elissara® influenced multiple biological pathways associated with healthy follicle function and the hair growth cycle. In human dermal papilla cells, Elissara® increased cell proliferation to approximately 2.5 times that of untreated controls.

Elissara® increased both collagen and signaling proteins associated with healthy hair-follicle function, including markers involved in cell proliferation, structural support and follicular signalling in human scalp explants. Elissara® was shown to help preserve growth-signalling IGF-1 protein levels important for hair-follicle development under environmental stress as well as reduce markers of oxidative damage, in scalp tissue exposed to PM2.5 pollution and UVA-induced environmental stress.

Beauty from skin to strand

"Elissara was initially developed as a natural inner beauty botanical formula to support the skin against pollution and UV exposure," informs Daniel González-Hedström, PhD, R&D Director for SuanNutra." It later exhibited scalp health benefits in a clinical study involving 66 women where daily oral supplementation significantly improved scalp moisturization and hydration, and reduced sebum levels and scalp redness. The benefits were also reflected in participants' self-assessments, with almost 79% reporting healthier-looking hair and 76% noting enhanced shine. Close to 80% of them reported that their hair felt stronger. This is what inspired us to further explore its potential in supporting hair growth."

The science of hair growth

Hair growth and follicular function are complex, shaped by a mix of genetics, hormonal changes, and inflammation, alongside lifestyle and environmental factors that can influence hair follicles. Androgens, particularly dihydrotestosterone (DHT), are known to contribute to shortening the anagen (growth) phase and shrinking hair follicles, while declining estrogen levels in women, particularly during menopause, may lead to hair thinning. Preclinical research showed that Elissara® may help support a healthier hormonal environment around the hair follicle by modulating pathways linked to DHT.

"Rather than relying on a single pathway, Elissara® combines four standardised, polyphenol-rich botanicals selected to provide complementary biological activity," says González-Hedström. "We are gradually unearthing Elissara®'s potential benefits on hair resilience. The findings of this preclinical trial provide new insights into its pathways of action and help us understand how the composition may support healthy follicular function. The next step is to investigate whether these mechanistic findings translate into measurable hair benefits in a clinical setting."

Previously marketed under the name "Zeropollution®," Elissara® is backed by two clinical trials demonstrating its positive impact on scalp condition and the hair's appearance. At a daily dose of 250 mg, it is available in various formats including tablets, capsules, or softgels.

Visit SuanNutra at Vitafoods Asia, in Bangkok, on September 2-4, booth #H5-E21 to discover how science is transformed into visible results.

About Monteloeder 

Monteloeder, SL contributes innovation and scientific rigor to the development of botanical ingredients, and by featuring proprietary patented products supported by clinical studies. Its Visible Health Platform™ reflects the company's strategic approach to translating clinical science into tangible, consumer-perceivable benefits. The platform is built upon three key pillars that address today's most relevant health areas: Visible Metabolic Health™, Visible Balance™ and Visible Radiance Monteloeder is a subsidiary of SuanNutra, which boasts a rich heritage of more than 125 years of combined experience in the European, US and Asian nutraceutical sector.

Company contact 
Monteloeder, S.L., a subsidiary of SuanNutra
Mariana Ortega
Science Marketing Manager
E-mail: [email protected]
Website: www.suannutra.com

Press Contact
NutriPR
Liat Simha 
Tel: +972-9-9742893
E-mail: [email protected] 
Website: www.nutripr.com

SOURCE Monteloeder, S.L.

21%

more press release views with 
Request a Demo

Modal title

Also from this source

RelaxPLX® Gains Health Canada License, and South Korean Sleep Quality Support Claim

RelaxPLX® Gains Health Canada License, and South Korean Sleep Quality Support Claim

Monteloeder, SL, a subsidiary of SUANNUTRA SA, announces RelaxPLX® has officially received individual license approval for its sleep quality support...

Consumers report feeling lighter, more motivated, mindful, and happier with Montoloeder's Metabolaid® weight-control formulation

Consumers report feeling lighter, more motivated, mindful, and happier with Montoloeder's Metabolaid® weight-control formulation

Results from a recent consumer study reveal Metabolaid®, a botanical blend formulated by Monteloeder, a SUANNUTRA S.L. company helps consumers take...

More Releases From This Source

Explore

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Cosmetics and Personal Care

Cosmetics and Personal Care

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.